Charles Schwab Investment Management »

Cytek Biosciences shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Cytek Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cytek Biosciences held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytek Biosciences by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.7M 1.0M 5.54
2024-06-30 $5.1M 918k 5.58
2024-03-31 $6.0M 901k 6.71
2023-12-31 $8.0M 880k 9.12
2023-09-30 $4.6M 836k 5.52
2023-06-30 $6.0M 700k 8.54
2023-03-31 $6.1M 669k 9.19
2022-12-31 $6.8M 668k 10.21
2022-09-30 $9.6M 655k 14.72
2022-06-30 $3.4M 315k 10.73
2022-03-31 $3.1M 290k 10.78
2021-12-31 $1.7M 106k 16.33
2021-09-30 $2.2M 103k 21.42